coronavirus pandemic Applications
-
Proprietary Technologies for Approach Towards COVID-19
First generation COVID-19 vaccines generate a strong antibody response against SARS-CoV-2, the virus that causes COVID-19. These vaccines elicit neutralizing antibodies that can recognize the surface Spike protein of the virus and attack it before it infects cells. However, antibody responses may wane over time and long-term durability of protection remains unknown. Additionally, mutations in SARS-CoV-2 continuously arise, including in the Spike protein, and may further reduce clinical protection derived from ...
By Gritstone Bio based in Emeryville, CALIFORNIA (USA).
-
Wound care management solutions for skilled nursing facilities sector
Swift Virtual Wound ensures your patients continue to receive vital wound care, safely. New telehealth wound care technology and expert clinical network will ensure continuity of wound management at your facility while eliminating external ...
By Swift Medical based in Toronto, ONTARIO (CANADA).
-
Nanotechnology for COVID-19
In the face of the coronavirus pandemic, it is time for the nanotechnology community to ...
By Phornano Holding GmbH based in Korneuburg, AUSTRIA.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you